Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990;100(3):316-22.
doi: 10.1007/BF02244599.

Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats

Affiliations

Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats

T Yamamoto et al. Psychopharmacology (Berl). 1990.

Abstract

Using a repeated acquisition procedure in a three-panel runway apparatus, the effects of minaprine on the impairment of working memory produced by scopolamine, ethylcholine aziridinium ion (AF64A) or cerebral ischemia were investigated in rats. Minaprine (3.2-32 mg/kg IP) as well as idebenone (10-100 mg/kg IP) and physostigmine (0.1-0.32 mg/kg IP) dose-dependently reduced the increase of errors (pushes made on the two incorrect panels located at each choice point) induced by 0.56 mg/kg IP scopolamine. Cerebral ischemia for 5 min caused a significant increase of errors in the runway task. Minaprine at 3.2 and 10 mg/kg administered IP immediately after blood recirculation and again 30 min before the runway test conducted 24 h after ischemia, significantly reduced increases in errors expected to occur after 5 min of ischemia. Physostigmine 0.1 mg/kg similarly attenuated the increase in errors in ischemic rats. However, minaprine at doses up to 32 mg/kg IP failed to reduce the increase of errors induced by AF64A 2.5 nmol injected into the dorsal hippocampus. These findings suggest that minaprine exerts an ameliorating effect on amnesia produced by scopolamine and cerebral ischemia, probably through mediation of its stimulant action on central cholinergic systems.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Jpn J Pharmacol. 1984 Nov;36(3):349-56 - PubMed
    1. Brain Res. 1977 Nov 18;136(3):487-500 - PubMed
    1. Stroke. 1979 May-Jun;10(3):267-72 - PubMed
    1. Lancet. 1976 Dec 25;2(8000):1403 - PubMed
    1. Brain Res. 1984 Oct 29;321(1):91-102 - PubMed

MeSH terms

LinkOut - more resources